Hemostats Market Overview
The global Hemostats Market is experiencing steady growth driven by rising surgical volumes, an aging population, increasing prevalence of chronic diseases, the shift toward minimally invasive and robotic procedures, and growing demand for effective bleeding-control solutions. Advances in biopolymer materials, recombinant technologies, flowable formulations, and powder-based hemostatic products are further expanding clinical applications.
According to the Market Research Future report updated August 26, 2026, the global Hemostats Market was valued at USD 3.24 billion in 2025 and is projected to grow from USD 3.45 billion in 2026 to USD 6.06 billion by 2035, registering a CAGR of 6.45% during the forecast period of 2026–2035. North America accounted for 39.8% of the market in 2025, while Asia-Pacific is expected to be the fastest-growing region at a CAGR of 8.9%. Absorbable Hemostats represented the largest type segment with a 76.5% share, General Surgery accounted for 31.4% of application demand, and Hospitals & Clinics held a 68.4% share among end users.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
Key players driving innovation and competitiveness in the Hemostats Market include:
Baxter International
Johnson & Johnson (Ethicon)
Becton Dickinson
Integra LifeSciences
B. Braun Melsungen
Teleflex
Artivion
Advanced Medical Solutions Group
Stryker
Pfizer
CSL Behring
The Hemostats Market is being shaped by the recovery and expansion of surgical procedures, increasing adoption of minimally invasive and robotic surgery, and the need for reliable bleeding control among complex and anticoagulated patients. Materials science is also transforming the market, with recombinant thrombin, alginate, chitosan, collagen, and other engineered materials supporting faster clot initiation and improved product performance. Powder and flowable formats are gaining importance because they can conform to irregular bleeding surfaces and can be delivered through minimally invasive surgical systems.
The Hemostats Market can be segmented by Type, Formulation, Application, and End User. By type, the market includes Absorbable Hemostats and Non-Absorbable Hemostats. By formulation, it comprises Matrix and Gel, Sheets and Pads, Sponges, Powder, and Other Formulations. Applications include General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Gynecological & Urological Surgery, and Other Applications, while end users include Hospitals & Clinics, Ambulatory Surgical Centers, and Other End Users.
The market presents significant opportunities through powder and flowable hemostatic formats, emerging-market hospital infrastructure development, trauma and prehospital care, outcome-linked contracting, and plant-derived or synthetic alternatives to animal-sourced materials. Asia-Pacific is particularly attractive as expanding healthcare capacity in China and India increases surgical volumes, while localization of manufacturing can help suppliers address procurement and cost pressures.
Recent Developments and Market Trends:
Absorbable Hemostats continue to dominate the market with a 76.5% share as surgeons favor products that eliminate the need for retrieval following procedures.
Powder formulations are emerging as a high-growth opportunity because sprayable products can address diffuse bleeding and irregular anatomical surfaces where conventional sheets may be less effective.
Ambulatory Surgical Centers are expanding at an 8.4% CAGR as more procedures migrate from inpatient hospitals to outpatient settings, increasing demand for compact, cost-efficient hemostatic products.
Biopolymer and recombinant material innovation is gaining momentum as manufacturers seek alternatives that improve performance while reducing dependence on animal-derived and plasma-derived raw materials.
Asia-Pacific is the fastest-growing regional market at an 8.9% CAGR, supported by hospital capacity expansion, rising surgical volumes, and increasing local manufacturing capabilities.
Reasons to Buy the Report:
Understand the current market size, growth trajectory, and forecast outlook for the global Hemostats Market through 2035.
Analyze the leading type, formulation, application, end-user, and regional segments shaping market demand.
Evaluate emerging opportunities in powder and flowable products, trauma care, ambulatory surgery, and emerging healthcare markets.
Identify technological developments involving recombinant materials, biopolymers, synthetic substitutes, and minimally invasive delivery systems.
Assess competitive dynamics, supplier positioning, regulatory challenges, and strategic growth opportunities across the global Hemostats Market.
Future Outlook:
The Hemostats Market is expected to maintain steady growth through 2035 as surgical volumes rise and healthcare providers increasingly prioritize efficient bleeding control, minimally invasive procedures, and blood-conservation strategies. Absorbable Hemostats will remain the dominant type with a 76.5% share in 2025, while Non-Absorbable Hemostats are projected to grow at a 7.0% CAGR. Matrix and Gel formulations lead the market by value at USD 1.11 billion in 2025, while Powder formulations represent a key growth opportunity at USD 0.37 billion. General Surgery will remain the largest application with a 31.4% share, while Orthopedic Surgery is projected to grow at a 7.3% CAGR. Hospitals & Clinics will continue to represent the largest end-user segment with a 68.4% share, whereas Ambulatory Surgical Centers are expected to expand at an 8.4% CAGR. North America will retain its leadership with a 39.8% market share, while Asia-Pacific will remain the fastest-growing region at 8.9% CAGR. Overall, the global Hemostats Market is projected to increase from USD 3.24 billion in 2025 to USD 6.06 billion by 2035 at a CAGR of 6.45%.
➤➤Explore Our Latest Related Reports:
